Katugampola, Sumudu
Wang, Jianchao
Prasad, Aprameya
Sofou, Stavroula
Howell, Roger W. http://orcid.org/0000-0002-7057-8110
Funding for this research was provided by:
National Cancer Institute (1R01CA245139)
Article History
Received: 10 January 2022
Accepted: 14 June 2022
First Online: 8 July 2022
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Sumudu Katugampola (SK), Jianchao Wang (JW), and Roger W. Howell (RWH) declare they have financial interests. RWH holds patent US 9,623,262 patent for MIRDcell V2. SK, JW, and RWH have petitioned Rutgers University to apply for a patent for MIRDcell V3.